Eight Roads Ventures: A Global Investor with a Dedicated India Platform
Eight Roads Ventures is a global venture capital platform investing in technology and healthcare across multiple regions. Its India platform focuses on enterprise SaaS, consumer, fintech, healthcare, and life sciences from early to growth stages. Eight Roads reports $1.6 billion in capital allocated and 80+ Indian portfolio companies. Its India healthcare platform includes a dedicated $250 million fund.
Overview
Eight Roads Ventures is a global venture capital platform that began investing in Boston in 1969. The platform now has investment teams across China, India, Japan, Europe and Israel, with the US business operating through its sister fund, F-Prime. It invests primarily in technology and healthcare companies.
The India business has operated locally since 2007. Its current India portfolio spans technology, consumer, financial services, and healthcare. Eight Roads' India team reports more than 80 portfolio companies and $1.6 billion in capital allocated.
Investment Focus and Stage
Eight Roads invests across early and growth stages. Its India platform focuses on healthcare and technology, including enterprise SaaS, consumer, fintech, healthcare services, digital health, medtech, and life sciences.
The firm does not limit its India investments to Series A and Series B. Its portfolio includes businesses at different stages, including Everstage, where Eight Roads led a $30 million Series B round, and SPRY Therapeutics, which raised a $15 million Series A round.
For its dedicated India healthcare fund, Eight Roads stated that it would make minority investments from smaller amounts up to $40 million. The fund covers life sciences, healthcare services, consumer health, and digital health.
Fund Size and Portfolio
Eight Roads' global website currently reports more than 350 portfolio companies, 35+ IPOs, and more than $5 billion in AUM. Its India platform reports $1.6 billion in capital allocated and more than 80 portfolio companies.
In 2022, Eight Roads announced a dedicated $250 million India healthcare and life sciences fund. The fund was designed to invest in 15 to 20 additional companies, with investments ranging from smaller amounts up to $40 million.
The India portfolio includes Icertis, Shadowfax, PharmEasy, Northern Arc, Laurus Labs, Everstage, and other companies across technology, consumer, financial services, and healthcare. The firm's India portfolio page currently shows 70 results.
Leadership
Prem Pavoor is Senior Partner and Head of India & Healthcare Investments at Eight Roads. He has led the firm's India healthcare investment activities.
Aditya Systla is a Partner at Eight Roads Ventures and has worked on investments in Indian technology companies, including Everstage and Exponent Energy. Chintan Kothari is also a Partner focused on the Indian healthcare sector.